Search

Your search keyword '"ERα"' showing total 229 results

Search Constraints

Start Over You searched for: Descriptor "ERα" Remove constraint Descriptor: "ERα" Database OpenAIRE Remove constraint Database: OpenAIRE
229 results on '"ERα"'

Search Results

1. Enzymes aldo-keto reductases and estrogen receptors as potential predictive markers of endometrial cancer and ovarian cancer

2. The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer

3. Epigenetics in Canine Mammary Tumors: Upregulation of miR-18a and miR-18b Oncogenes Is Associated with Decreased ERS1 Target mRNA Expression and ERα Immunoexpression in Highly Proliferating Carcinomas

4. R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway

5. CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3

6. Bioinformatics Analysis of the Prognostic Significance of CAND1 in ERα-Positive Breast Cancer

7. Histone Deacetylase 3 Governs β-Estradiol-ERα-Involved Endometrial Tumorigenesis via Inhibition of STING Transcription

8. Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer

9. Expresión diferencial de receptores de estrógenos en diferentes tejidos de un modelo murino de menopausia experimental

10. CAXII, un marqueur membranaire pour isoler et étudier les cellules tumorales luminales mammaires

11. ERα down‐regulates carbohydrate responsive element binding protein and decreases aerobic glycolysis in liver cancer cells

12. PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways

13. Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ER to inhibit RANKL signaling

14. Association of the Estrogen Receptor 1 Polymorphisms rs2046210 and rs9383590 with the Risk, Age at Onset and Prognosis of Breast Cancer

15. Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies

16. ERα, A Key Target for Cancer Therapy: A Review

17. ERα, A Key Target for Cancer Therapy: A Review

18. A Supramolecular Stabilizer of the 14‐3‐3ζ/ERα Protein‐Protein Interaction with a Synergistic Mode of Action

19. YB-1 interplays with ERα to regulate the stemness and differentiation of ER-positive breast cancer stem cells

20. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network

21. The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression

22. Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells

23. Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment

24. Cystatin SN Affects Cell Proliferation by Regulating the ERα/PI3K/AKT/ERα Loopback Pathway in Breast Cancer

25. Cystatin SN Affects Cell Proliferation by Regulating the ERα/PI3K/AKT/ERα Loopback Pathway in Breast Cancer

26. Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice

27. Knockdown of LMTK3 in the Endometrioid Adenocarcinoma Cell Line Ishikawa: Inhibition of Growth and Estrogen Receptor α

28. Myocardial Expression of Estrogen Receptor-mRNA Is Associated With Lower Markers of Post-operative Organ Damage in Young Patients With Congenital Cardiac Defect

29. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance

30. The impact of p53 mutations on the ER status and estrogen dependent growth of breast tumours

31. Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer

32. Regulation of ERα Stability and Estrogen Signaling in Breast Cancer by HOIL-1

33. Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer

34. Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer

35. Isolation and characterization of a new basal-like luminal progenitor in human breast tissue

36. Estradiol accelerates liver regeneration through estrogen receptor α

37. Regulation of murine skeletal muscle growth by STAT5B is age- and sex-specific

38. The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

39. Activation of hepatic estrogen receptor-α increases energy expenditure by stimulating the production of fibroblast growth factor 21 in female mice

40. Estrogen receptor-α-miR-1271-SNAI2 feedback loop regulates transforming growth factor-β-induced breast cancer progression

41. Chlorotoxin targets ERα/VASP signaling pathway to combat breast cancer

42. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function

43. Localization of Estrogen Receptors in Male Reproductive Tissues and Sperm Cells – A Review

44. Estrogen Decreases Cytoskeletal Organization by Forming an ERα/SHP2/c-Src Complex in Osteoclasts to Protect against Ovariectomy-Induced Bone Loss in Mice

45. The impact of CBP expression in estrogen receptor-positive breast cancer

46. Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes

47. LncRNA APTR Promotes Uterine Leiomyoma Cell Proliferation by Targeting ERα to Activate the Wnt/β-Catenin Pathway

48. How Protein Methylation Regulates Steroid Receptor Function

49. Estrogen Receptors Alpha and Beta Mediate Synaptic Transmission in the PFC and Hippocampus of Mice

50. Analysis of the ATAD2 gene effect on the genes involved in epithelial mesenchymal transition in estrogen positive and negative breast cancers

Catalog

Books, media, physical & digital resources